<DOC>
	<DOCNO>NCT02323659</DOCNO>
	<brief_summary>Comparison methotrexate versus interferon-alfa 2b efficacy , safety quality life patient primary cutaneous T-cell lymphoma failure topical phototherapy treatment .</brief_summary>
	<brief_title>Comparison Methotrexate Versus Interferon-alfa 2b Patients With Primary Cutaneous T-cell Lymphomas</brief_title>
	<detailed_description>Methotrexate interferon widely use drug treatment patient cutaneous T-cell Lymphomas . Efficacy safety drug never compare directly one study . Patients randomly assign receive Methotrexate Interferon Alfa 2b . Treatment continue disease progression development intolerable toxicity . Study conduct analyse compare efficacy , safety quality life provide Methotrexate Interferon Alfa 2b .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Mycosis Fungoides</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>1 . Histologically confirm primary cutaneous Tcell lymphoma ( CTCL ) 2 . Age ≥ 18 year 3 . Performance status WHO &lt; =2 4 . Subject must adequate bone marrow , renal hepatic function 5 . Topical phototherapy treatment failure past 6 . Signed informed consent 1 . Subject receive prior systemic methotrexate interferon therapy 2 . Unacceptable methotrexate interferon treatment toxicity past 3 . Inadequate bone marrow , renal hepatic function follow : Bone Marrow : Absolute neutrophil count ( ANC ) &lt; 1,500/mm 3 ( 1.5 × 10 9 /L ) ; Platelets &lt; 100,000/mm 3 ( 100 × 10 9 /L ) ; Hemoglobin &lt; 9.0 g/dL ( 1.4 mmol/L ) ; Renal function : Creatinine &gt; 1.5 x Upper limit normal ( ULN ) Hepatic function : Aspartate Alanine transaminase ( AST ALT ) &gt; 3× ULN ; bilirubin &gt; 1.5 × ULN Active hepatitis B hepatitis C 4. anorexia 5. major depression suicidal ideation suicide attempt past 6 . Symptomatic congestive heart failure 7 . Epilepsia symptomatic central nervous system dysfunction 8. active skin infection relate underlying CTCL , active Tuberculosis , HIV infection 9 . Subject pregnant lactating 10 . Psychiatric illness/social situation would limit compliance study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Mycosis Fungoides</keyword>
	<keyword>Cutaneous T-Cell Lymphoma</keyword>
	<keyword>Interferon</keyword>
	<keyword>Methotrexate</keyword>
</DOC>